Chief Scientific Officer Prof Dolores Schendel appointed new Chief Executive Officer of Medigene AG
Dave Lemus appointed Chief Operating Officer of Medigene AG and Chief Executive Officer of Medigene Inc. in the United States
Martinsried/Munich, 17 December 2015. Medigene AG (Frankfurt Stock Exchange: MDG1) announced today that the Supervisory Board has resolved important changes and additions to the senior management team to better align the organisational structure with the strategic goals of the company in immuno-oncology and to expand Medigene’s presence in the United States.
{iframe}http://www.nasdaq.com/press-release/medigene-ag-announces-key-management-changes-20151217-00906{/iframe}